{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:29:58Z","timestamp":1786980598023,"version":"build-2736575974"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Odontology"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s10266-009-0118-3","type":"journal-article","created":{"date-parts":[[2010,2,14]],"date-time":"2010-02-14T19:06:11Z","timestamp":1266174371000},"page":"15-25","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":126,"title":["Antifungal drug resistance of oral fungi"],"prefix":"10.1007","volume":"98","author":[{"given":"Masakazu","family":"Niimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman A.","family":"Firth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,16]]},"reference":[{"key":"118_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1600-0757.2008.00291.x","volume":"49","author":"L.P. Samaranayake","year":"2009","unstructured":"Samaranayake LP, Keung Leung W, Jin L. Oral mucosal fungal infections. Periodontology 2000 2009;49:39\u201359.","journal-title":"Periodontology 2000"},{"key":"118_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1177\/10454411990100030701","volume":"10","author":"R.D. Cannon","year":"1999","unstructured":"Cannon RD, Chaffin WL. Oral colonization by Candida albicans. Crit Rev Oral Biol Med 1999;10:359\u2013383.","journal-title":"Crit Rev Oral Biol Med"},{"key":"118_CR3","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1177\/00220345950740050301","volume":"74","author":"R.D. Cannon","year":"1995","unstructured":"Cannon RD, Holmes AR, Mason AB, Monk BC. Oral Candida: clearance, colonization, or candidiasis? J Dent Res 1995;74:1152\u20131161.","journal-title":"J Dent Res"},{"key":"118_CR4","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1128\/CMR.17.4.729-759.2004","volume":"17","author":"L. de Repentigny","year":"2004","unstructured":"de Repentigny L, Lewandowski D, Jolicoeur P. Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection. Clin Microbiol Rev 2004;17:729\u2013759.","journal-title":"Clin Microbiol Rev"},{"key":"118_CR5","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.oraloncology.2005.11.010","volume":"42","author":"A.N. Davies","year":"2006","unstructured":"Davies AN, Brailsford SR, Beighton D. Oral candidosis in patients with advanced cancer. Oral Oncol 2006;42:698\u2013702.","journal-title":"Oral Oncol"},{"key":"118_CR6","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1086\/504490","volume":"43","author":"M.A. Pfaller","year":"2006","unstructured":"Pfaller MA, Pappas PG, Wingard JR. Invasive fungal pathogens: current epidemiological trends. Clin Infect Dis 2006;43:S3\u2013S14.","journal-title":"Clin Infect Dis"},{"key":"118_CR7","first-page":"349","volume-title":"Candida and Candidiasis","author":"D. Sanglard","year":"2002","unstructured":"Sanglard D, Bille J. Current understanding of the modes of action of and resistance mechanisms to conventional and emerging antifungal agents for treatment of Candida infections. In: Calderone RA, editor. Candida and Candidiasis. Washington, DC: ASM Press; 2002. p. 349\u2013383"},{"key":"118_CR8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/13693780500138971","volume":"43","author":"R.A. Akins","year":"2005","unstructured":"Akins RA. An update on antifungal targets and mechanisms of resistance in Candida albicans. Med Mycol 2005;43:285\u2013318.","journal-title":"Med Mycol"},{"key":"118_CR9","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/S0140-6736(02)08162-X","volume":"359","author":"D.P. Kontoyiannis","year":"2002","unstructured":"Kontoyiannis DP, Lewis RE. Antifungal drug resistance of pathogenic fungi. Lancet 2002;359:1135\u20131144.","journal-title":"Lancet"},{"key":"118_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1128\/CMR.00051-08","volume":"22","author":"R.D. Cannon","year":"2009","unstructured":"Cannon RD, Lamping E, Holmes AR, et al. Efflux-mediated antifungal drug resistance. Clin Microbiol Rev 2009;22:291\u2013321.","journal-title":"Clin Microbiol Rev"},{"key":"118_CR11","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1177\/0022034509346811","volume":"88","author":"K. Hojo","year":"2009","unstructured":"Hojo K, Nagaoka S, Ohshima T, Maeda N. Bacterial interactions in dental biofilm development. J Dent Res 2009;88:982\u2013990.","journal-title":"J Dent Res"},{"key":"118_CR12","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1601-0825.2007.01424.x","volume":"14","author":"C.J. Seneviratne","year":"2008","unstructured":"Seneviratne CJ, Jin L, Samaranayake LP. Biofilm lifestyle of Candida: a mini review. Oral Dis 2008;14:582\u2013590.","journal-title":"Oral Dis"},{"key":"118_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1177\/0022034508329273","volume":"88","author":"J.M. ten Cate","year":"2009","unstructured":"ten Cate JM, Klis FM, Pereira-Cenci T, Crielaard W, de Groot PW. Molecular and cellular mechanisms that lead to Candida biofilm formation. J Dent Res 2009;88:105\u2013115.","journal-title":"J Dent Res"},{"key":"118_CR14","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1177\/154405910808701104","volume":"87","author":"B.J. Keijser","year":"2008","unstructured":"Keijser BJ, Zaura E, Huse SM, et al. Pyrosequencing analysis of the oral microflora of healthy adults. J Dent Res 2008;87:1016\u20131020.","journal-title":"J Dent Res"},{"key":"118_CR15","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.1128\/JCM.43.11.5721-5732.2005","volume":"43","author":"J.A. Aas","year":"2005","unstructured":"Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 2005;43:5721\u20135732.","journal-title":"J Clin Microbiol"},{"key":"118_CR16","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1128\/JB.183.12.3770-3783.2001","volume":"183","author":"B.J. Paster","year":"2001","unstructured":"Paster BJ, Boches SK, Galvin JL, et al. Bacterial diversity in human subgingival plaque. J Bacteriol 2001;183:3770\u20133783.","journal-title":"J Bacteriol"},{"key":"118_CR17","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/j.1469-0691.2008.02070.x","volume":"14","author":"P.C. Woo","year":"2008","unstructured":"Woo PC, Lau SK, Teng JL, Tse H, Yuen KY. Then and now: use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories. Clin Microbiol Infect 2008;14:908\u2013934.","journal-title":"Clin Microbiol Infect"},{"key":"118_CR18","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1600-0765.2005.00793.x","volume":"40","author":"M. Sakamoto","year":"2005","unstructured":"Sakamoto M, Umeda M, Benno Y. Molecular analysis of human oral microbiota. J Periodont Res 2005;40:277\u2013285.","journal-title":"J Periodont Res"},{"key":"118_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/01.don.0000157989.44949.26","volume":"31","author":"J.F. Siqueira Jr","year":"2005","unstructured":"Siqueira JF Jr, Rocas IN. Exploiting molecular methods to explore endodontic infections: Part 1. Current molecular technologies for microbiological diagnosis. J Endod 2005;31:411\u2013423.","journal-title":"J Endod"},{"key":"118_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11046-008-9149-5","volume":"167","author":"V.G. Sivakumar","year":"2009","unstructured":"Sivakumar VG, Shankar P, Nalina K, Menon T. Use of CHRO-Magar in the differentiation of common species of Candida. Mycopathologia 2009;167:47\u201349.","journal-title":"Mycopathologia"},{"key":"118_CR21","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1128\/jcm.32.8.1923-1929.1994","volume":"32","author":"F.C. Odds","year":"1994","unstructured":"Odds FC, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 1994;32:1923\u20131929.","journal-title":"J Clin Microbiol"},{"key":"118_CR22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1128\/JCM.36.2.329-334.1998","volume":"36","author":"D. Sullivan","year":"1998","unstructured":"Sullivan D, Coleman D. Candida dubliniensis: characteristics and identification. J Clin Microbiol 1998;36:329\u2013334.","journal-title":"J Clin Microbiol"},{"key":"118_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1601-0825.2000.tb00314.x","volume":"6","author":"D.W. Williams","year":"2000","unstructured":"Williams DW, Lewis MA. Isolation and identification of Candida from the oral cavity. Oral Dis 2000;6:3\u201311.","journal-title":"Oral Dis"},{"key":"118_CR24","first-page":"387","volume-title":"Candida and candidiasis","author":"M.D. Richardson","year":"2002","unstructured":"Richardson MD, Carlson P. Culture- and non-culture-based diagnostics for Candida species. In: Calderone R, editor. Candida and candidiasis. Washington, DC: ASM Press; 2002. p. 387\u2013394."},{"key":"118_CR25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1399-302X.2008.00447.x","volume":"24","author":"G. Liguori","year":"2009","unstructured":"Liguori G, Di Onofrio V, Lucariello A, et al. Oral candidiasis: a comparison between conventional methods and multiplex polymerase chain reaction for species identification. Oral Microbiol Immunol 2009;24:76\u201378.","journal-title":"Oral Microbiol Immunol"},{"key":"118_CR26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0167-7012(02)00106-9","volume":"51","author":"G.M. Wall-Manning","year":"2002","unstructured":"Wall-Manning GM, Sissons CH, Anderson SA, Lee M. Checkerboard DNA-DNA hybridisation technology focused on the analysis of gram-positive cariogenic bacteria. J Microbiol Methods 2002;51:301\u2013311.","journal-title":"J Microbiol Methods"},{"key":"118_CR27","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1139\/W08-160","volume":"55","author":"C. do Nascimento","year":"2009","unstructured":"do Nascimento C, Ferreira de Albuquerque R Jr, Issa JP, et al. Use of the DNA checkerboard hybridization method for detection and quantitation of Candida species in oral microbiota. Can J Microbiol 2009;55:622\u2013626.","journal-title":"Can J Microbiol"},{"key":"118_CR28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1046\/j.0902-0055.2001.00095.x","volume":"17","author":"A.N. Davies","year":"2002","unstructured":"Davies AN, Brailsford S, Broadley K, Beighton D. Oral yeast carriage in patients with advanced cancer. Oral Microbiol Immunol 2002;17:79\u201384.","journal-title":"Oral Microbiol Immunol"},{"key":"118_CR29","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1136\/jcp.2006.040782","volume":"60","author":"G. Liguori","year":"2007","unstructured":"Liguori G, Lucariello A, Colella G, De Luca A, Marinelli P. Rapid identification of Candida species in oral rinse solutions by PCR. J Clin Pathol 2007;60:1035\u20131039.","journal-title":"J Clin Pathol"},{"key":"118_CR30","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1128\/JCM.42.5.2101-2107.2004","volume":"42","author":"P.L. White","year":"2004","unstructured":"White PL, Williams DW, Kuriyama T, et al. Detection of Candida in concentrated oral rinse cultures by real-time PCR. J Clin Microbiol 2004;42:2101\u20132107.","journal-title":"J Clin Microbiol"},{"key":"118_CR31","volume-title":"Candida and candidiasis","author":"F.C. Odds","year":"1988","unstructured":"Odds FC. Candida and candidiasis. Second edn. London: Bailli\u00e8re Tindall; 1988.","edition":"Second edn."},{"key":"118_CR32","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1099\/13500872-141-7-1507","volume":"141","author":"D.J. Sullivan","year":"1995","unstructured":"Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 1995;141:1507\u20131521.","journal-title":"Microbiology"},{"key":"118_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.femsle.2005.09.015","volume":"253","author":"D.J. Sullivan","year":"2005","unstructured":"Sullivan DJ, Moran GP, Coleman DC. Candida dubliniensis: ten years on. FEMS Microbiol Lett 2005;253:9\u201317.","journal-title":"FEMS Microbiol Lett"},{"key":"118_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0003-9969(80)90147-8","volume":"25","author":"T.M. Arendorf","year":"1980","unstructured":"Arendorf TM, Walker DM. The prevalence and intra-oral distribution of Candida albicans in man. Arch Oral Biol 1980;25:1\u201310.","journal-title":"Arch Oral Biol"},{"key":"118_CR35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/10454411990100010501","volume":"10","author":"D.R. Radford","year":"1999","unstructured":"Radford DR, Challacombe SJ, Walter JD. Denture plaque and adherence of Candida albicans to denture-base materials in vivo and in vitro. Crit Rev Oral Biol Med 1999;10:99\u2013116.","journal-title":"Crit Rev Oral Biol Med"},{"key":"118_CR36","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1177\/00220345870660091701","volume":"66","author":"M.J. Schaeken","year":"1987","unstructured":"Schaeken MJ, Creugers TJ, Van der Hoeven JS. Relationship between dental plaque indices and bacteria in dental plaque and those in saliva. J Dent Res 1987;66:1499\u20131502.","journal-title":"J Dent Res"},{"key":"118_CR37","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1034\/j.1600-051X.2003.00420.x","volume":"30","author":"S. Sekino","year":"2003","unstructured":"Sekino S, Ramberg P, Uzel NG, Socransky S, Lindhe J. Effect of various chlorhexidine regimens on salivary bacteria and de novo plaque formation. J Clin Periodontol 2003;30:919\u2013925.","journal-title":"J Clin Periodontol"},{"key":"118_CR38","first-page":"333","volume-title":"Oral microbiology and immunology","author":"R.D. Cannon","year":"2006","unstructured":"Cannon RD, Firth NA. Fungi and fungal infections of the oral cavity. In: Lamont RJ, Burne RA, Lantz MS, LeBlanc DJ, editors. Oral microbiology and immunology. Washington, DC: ASM Press; 2006. p. 333\u2013348."},{"issue":"supplS50","key":"118_CR39","first-page":"e1","volume":"103","author":"L. Baccaglini","year":"2007","unstructured":"Baccaglini L, Atkinson JC, Patton LL, et al. Management of oral lesions in HIV-positive patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103(suppl S50):e1\u201323.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"supplS6","key":"118_CR40","first-page":"e1","volume":"103","author":"J.A. Ship","year":"2007","unstructured":"Ship JA, Vissink A, Challacombe SJ. Use of prophylactic antifungals in the immunocompromised host. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103(suppl S6):e1\u201314.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"118_CR41","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1590\/S1678-77572008000200002","volume":"16","author":"T. Pereira-Cenci","year":"2008","unstructured":"Pereira-Cenci T, Del Bel Cury AA, Crielaard W, Ten Cate JM. Development of Candida-associated denture stomatitis: new insights. J Appl Oral Sci 2008;16:86\u201394.","journal-title":"J Appl Oral Sci"},{"key":"118_CR42","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1086\/344658","volume":"36","author":"J. Loeffler","year":"2003","unstructured":"Loeffler J, Stevens DA. Antifungal drug resistance. Clin Infect Dis 2003;36:S31\u201341.","journal-title":"Clin Infect Dis"},{"key":"118_CR43","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1128\/CMR.12.1.40","volume":"12","author":"D.J. Sheehan","year":"1999","unstructured":"Sheehan DJ, Hitchcock CA, Sibley CM. Current and emerging azole antifungal agents. Clin Microbiol Rev 1999;12:40\u201379.","journal-title":"Clin Microbiol Rev"},{"issue":"suppl1","key":"118_CR44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/mmy.39.1.55.66","volume":"39","author":"C.M. Douglas","year":"2001","unstructured":"Douglas CM. Fungal beta(1,3)-d-glucan synthesis. Med Mycol 2001;39(suppl 1):55\u201366.","journal-title":"Med Mycol"},{"key":"118_CR45","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1128\/AAC.47.10.3085-3088.2003","volume":"47","author":"A. Gomez-Lopez","year":"2003","unstructured":"Gomez-Lopez A, Garcia-Effron G, Mellado E, et al. In vitro activities of three licensed antifungal agents against Spanish clinical isolates of Aspergillus spp. Antimicrob Agents Chemother 2003;47:3085\u20133088.","journal-title":"Antimicrob Agents Chemother"},{"key":"118_CR46","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1086\/421950","volume":"39","author":"W.J. Steinbach","year":"2004","unstructured":"Steinbach WJ, Benjamin DK Jr, Kontoyiannis DP, et al. Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. Clin Infect Dis 2004;39:192\u2013198.","journal-title":"Clin Infect Dis"},{"key":"118_CR47","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1128\/AAC.48.9.3217-3225.2004","volume":"48","author":"W.J. Steinbach","year":"2004","unstructured":"Steinbach WJ, Perfect JR, Schell WA, Walsh TJ, Benjamin DK Jr. In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection. Antimicrob Agents Chemother 2004;48:3217\u20133225.","journal-title":"Antimicrob Agents Chemother"},{"key":"118_CR48","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.drup.2006.01.001","volume":"8","author":"G. Chamilos","year":"2005","unstructured":"Chamilos G, Kontoyiannis DP. Update on antifungal drug resistance mechanisms of Aspergillus fumigatus. Drug Resist Update 2005;8:344\u2013358.","journal-title":"Drug Resist Update"},{"key":"118_CR49","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1086\/377210","volume":"188","author":"T.J. Walsh","year":"2003","unstructured":"Walsh TJ, Petraitis V, Petraitiene R, et al. Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B. J Infect Dis 2003;188:305\u2013319.","journal-title":"J Infect Dis"},{"key":"118_CR50","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S0014-5793(96)01360-9","volume":"400","author":"S.L. Kelly","year":"1997","unstructured":"Kelly SL, Lamb DC, Kelly DE, et al. Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol delta5,6-desaturation. FEBS Lett 1997;400:80\u201382.","journal-title":"FEBS Lett"},{"key":"118_CR51","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1086\/524071","volume":"46","author":"Z.A. Kanafani","year":"2008","unstructured":"Kanafani ZA, Perfect JR. Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact. Clin Infect Dis 2008;46:120\u2013128.","journal-title":"Clin Infect Dis"},{"key":"118_CR52","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1086\/313757","volume":"30","author":"M.S. Saag","year":"2000","unstructured":"Saag MS, Graybill RJ, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis 2000;30:710\u2013718.","journal-title":"Clin Infect Dis"},{"key":"118_CR53","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1128\/AAC.41.11.2471","volume":"41","author":"C.M. Douglas","year":"1997","unstructured":"Douglas CM, D\u2019Ippolito JA, Shei GJ, et al. Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-d-glucan synthase inhibitors. Antimicrob Agents Chemother 1997;41:2471\u20132479.","journal-title":"Antimicrob Agents Chemother"},{"key":"118_CR54","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1128\/iai.64.8.3244-3251.1996","volume":"64","author":"M.B. Kurtz","year":"1996","unstructured":"Kurtz MB, Abruzzo G, Flattery A, et al. Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies. Infect Immun 1996;64:3244\u20133251.","journal-title":"Infect Immun"},{"key":"118_CR55","doi-asserted-by":"crossref","first-page":"5686","DOI":"10.1128\/jb.176.18.5686-5696.1994","volume":"176","author":"C.M. Douglas","year":"1994","unstructured":"Douglas CM, Marrinan JA, Li W, Kurtz MB. A Saccharomyces cerevisiae mutant with echinocandin-resistant 1,3-beta-d-glucan synthase. J Bacteriol 1994;176:5686\u20135696.","journal-title":"J Bacteriol"},{"key":"118_CR56","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1093\/jac\/dkm095","volume":"59","author":"M.T. Baixench","year":"2007","unstructured":"Baixench MT, Aoun N, Desnos-Ollivier M, et al. Acquired resistance to echinocandins in Candida albicans: case report and review. J Antimicrob Chemother 2007;59:1076\u20131083.","journal-title":"J Antimicrob Chemother"},{"key":"118_CR57","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.drup.2007.04.002","volume":"10","author":"D.S. Perlin","year":"2007","unstructured":"Perlin DS. Resistance to echinocandin-class antifungal drugs. Drug Resist Update 2007;10:121\u2013130.","journal-title":"Drug Resist Update"},{"key":"118_CR58","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1128\/EC.00041-08","volume":"7","author":"L.E. Cowen","year":"2008","unstructured":"Cowen LE, Steinbach WJ. Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance. Eukaryot Cell 2008;7:747\u2013764.","journal-title":"Eukaryot Cell"},{"key":"118_CR59","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CMR.11.2.382","volume":"11","author":"T.C. White","year":"1998","unstructured":"White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 1998;11:382\u2013402.","journal-title":"Clin Microbiol Rev"},{"key":"118_CR60","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1099\/00221287-145-10-2701","volume":"145","author":"P. Marichal","year":"1999","unstructured":"Marichal P, Koymans L, Willemsens S, et al. Contribution of mutations in the cytochrome P450 14-alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology 1999;145:2701\u20132713.","journal-title":"Microbiology"},{"key":"118_CR61","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1128\/AAC.45.10.2676-2684.2001","volume":"45","author":"S. Perea","year":"2001","unstructured":"Perea S, Lopez-Ribot JL, Kirkpatrick WR, et al. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virusinfected patients. Antimicrob Agents Chemother 2001;45:2676\u20132684.","journal-title":"Antimicrob Agents Chemother"},{"key":"118_CR62","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/jac\/42.2.241","volume":"42","author":"D. Sanglard","year":"1998","unstructured":"Sanglard D, Ischer F, Koymans L, Bille J. Amino acid substitutions in the cytochrome P-450 lanosterol 14-alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrob Agents Chemother 1998;42:241\u2013253.","journal-title":"Antimicrob Agents Chemother"},{"key":"118_CR63","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1128\/AAC.40.12.2835","volume":"40","author":"G.D. Albertson","year":"1996","unstructured":"Albertson GD, Niimi M, Cannon RD, Jenkinson HF. Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance. Antimicrob Agents Chemother 1996;40:2835\u20132841.","journal-title":"Antimicrob Agents Chemother"},{"key":"118_CR64","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1126\/science.274.5287.546","volume":"274","author":"A. Goffeau","year":"1996","unstructured":"Goffeau A, Barrell BG, Bussey H, et al. Life with 6000 genes. Science 1996;274:546\u2013567.","journal-title":"Science"},{"key":"118_CR65","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/ng0297-137","volume":"15","author":"A. Decottignies","year":"1997","unstructured":"Decottignies A, Goffeau A. Complete inventory of the yeast ABC proteins. Nat Genet 1997;15:137\u2013145.","journal-title":"Nat Genet"},{"key":"118_CR66","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S0076-6879(98)92012-2","volume":"292","author":"D. Taglicht","year":"1998","unstructured":"Taglicht D, Michaelis S. Saccharomyces cerevisiae ABC proteins and their relevance to human health and disease. Methods Enzymol 1998;292:130\u2013162.","journal-title":"Methods Enzymol"},{"key":"118_CR67","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000088141","volume":"9","author":"M. Gaur","year":"2005","unstructured":"Gaur M, Choudhury D, Prasad R. Complete inventory of ABC proteins in human pathogenic yeast, Candida albicans. J Mol Microbiol Biotechnol 2005;9:3\u201315.","journal-title":"J Mol Microbiol Biotechnol"},{"key":"118_CR68","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nature02579","volume":"430","author":"B. Dujon","year":"2004","unstructured":"Dujon B, Sherman D, Fischer G, et al. Genome evolution in yeasts. Nature (Lond) 2004;430:35\u201344.","journal-title":"Nature (Lond)"},{"key":"118_CR69","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/nature04332","volume":"438","author":"W.C. Nierman","year":"2005","unstructured":"Nierman WC, Pain A, Anderson MJ, et al. Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. Nature (Lond) 2005;438:1151\u20131156.","journal-title":"Nature (Lond)"},{"key":"118_CR70","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1126\/science.1103773","volume":"307","author":"B.J. Loftus","year":"2005","unstructured":"Loftus BJ, Fung E, Roncaglia P, et al. The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans. Science 2005;307:1321\u20131324.","journal-title":"Science"},{"key":"118_CR71","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1128\/EC.00327-07","volume":"6","author":"T.T. Liu","year":"2007","unstructured":"Liu TT, Znaidi S, Barker KS, et al. Genome-wide expression and location analyses of the Candida albicans Tac1p regulon. Eukaryot Cell 2007;6:2122\u20132138.","journal-title":"Eukaryot Cell"},{"key":"118_CR72","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1128\/AAC.47.4.1220-1227.2003","volume":"47","author":"P.D. Rogers","year":"2003","unstructured":"Rogers PD, Barker KS. Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates. Antimicrob Agents Chemother 2003;47:1220\u20131227.","journal-title":"Antimicrob Agents Chemother"},{"key":"118_CR73","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1128\/AAC.41.7.1482","volume":"41","author":"T.C. White","year":"1997","unstructured":"White TC. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob Agents Chemother 1997;41:1482\u20131487.","journal-title":"Antimicrob Agents Chemother"},{"key":"118_CR74","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1128\/AAC.48.5.1773-1777.2004","volume":"48","author":"J.E. Bennett","year":"2004","unstructured":"Bennett JE, Izumikawa K, Marr KA. Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis. Antimicrob Agents Chemother 2004;48:1773\u20131777.","journal-title":"Antimicrob Agents Chemother"},{"key":"118_CR75","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1128\/AAC.43.11.2753","volume":"43","author":"D. Sanglard","year":"1999","unstructured":"Sanglard D, Ischer F, Calabrese D, Majcherczyk PA, Bille J. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Antimicrob Agents Chemother 1999;43:2753\u20132765.","journal-title":"Antimicrob Agents Chemother"},{"key":"118_CR76","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1046\/j.1365-2958.2003.03281.x","volume":"47","author":"B. Posteraro","year":"2003","unstructured":"Posteraro B, Sanguinetti M, Sanglard D, et al. Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter-encoding gene, CnAFR1, involved in the resistance to fluconazole. Mol Microbiol 2003;47:357\u2013371.","journal-title":"Mol Microbiol"},{"key":"118_CR77","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1128\/IAI.74.2.1352-1359.2006","volume":"74","author":"M. Sanguinetti","year":"2006","unstructured":"Sanguinetti M, Posteraro B, La Sorda M, et al. Role of AFR1, an ABC transporter-encoding gene, in the in vivo response to fluconazole and virulence of Cryptococcus neoformans. Infect Immun 2006;74:1352\u20131359.","journal-title":"Infect Immun"},{"key":"118_CR78","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/mmy.39.1.109.116","volume":"39","author":"S.K. Katiyar","year":"2001","unstructured":"Katiyar SK, Edlind TD. Identification and expression of multidrug resistance-related ABC transporter genes in Candida krusei. Med Mycol 2001;39:109\u2013116.","journal-title":"Med Mycol"},{"key":"118_CR79","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1128\/AAC.01095-08","volume":"53","author":"E. Lamping","year":"2009","unstructured":"Lamping E, Ranchod A, Nakamura K, et al. Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei. Antimicrob Agents Chemother 2009;53:354\u2013369.","journal-title":"Antimicrob Agents Chemother"},{"key":"118_CR80","doi-asserted-by":"publisher","first-page":"D452","DOI":"10.1093\/nar\/gkl899","volume":"35","author":"M.B. Arnaud","year":"2007","unstructured":"Arnaud MB, Costanzo MC, Skrzypek MS, et al. Sequence resources at the Candida Genome Database. Nucleic Acids Res 2007;35:D452\u2013D456.","journal-title":"Nucleic Acids Res"},{"key":"118_CR81","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/BF02703742","volume":"26","author":"A. Kohli","year":"2001","unstructured":"Kohli A, Gupta V, Krishnamurthy S, Hasnain SE, Prasad R. Specificity of drug transport mediated by CaMDR1: a major facilitator of Candida albicans. J Biosci 2001;26:333\u2013339.","journal-title":"J Biosci"},{"key":"118_CR82","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1128\/AAC.45.12.3366-3374.2001","volume":"45","author":"K. Nakamura","year":"2001","unstructured":"Nakamura K, Niimi M, Niimi K, et al. Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters. Antimicrob Agents Chemother 2001;45:3366\u20133374.","journal-title":"Antimicrob Agents Chemother"},{"key":"118_CR83","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1128\/AAC.42.12.3065","volume":"42","author":"R. Franz","year":"1998","unstructured":"Franz R, Kelly SL, Lamb DC, et al. Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob Agents Chemother 1998;42:3065\u20133072.","journal-title":"Antimicrob Agents Chemother"},{"key":"118_CR84","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S1567-1356(03)00240-X","volume":"4","author":"D.J. Sullivan","year":"2004","unstructured":"Sullivan DJ, Moran GP, Pinjon E, et al. Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans. FEMS Yeast Res 2004;4:369\u2013376.","journal-title":"FEMS Yeast Res"},{"key":"118_CR85","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1128\/AAC.00463-08","volume":"52","author":"A.R. Holmes","year":"2008","unstructured":"Holmes AR, Lin YH, Niimi K, et al. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates. Antimicrob Agents Chemother 2008;52:3851\u20133862.","journal-title":"Antimicrob Agents Chemother"},{"key":"118_CR86","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.tripleo.2005.10.052","volume":"102","author":"A.R. Holmes","year":"2006","unstructured":"Holmes AR, van der Wielen P, Cannon RD, Ruske D, Dawes P. Candida albicans binds to saliva proteins selectively adsorbed to silicone. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102:488\u2013494.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"118_CR87","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1128\/CMR.17.2.255-267.2004","volume":"17","author":"E.M. Kojic","year":"2004","unstructured":"Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev 2004;17:255\u2013267.","journal-title":"Clin Microbiol Rev"},{"key":"118_CR88","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/000348940211100302","volume":"111","author":"G.J. Elving","year":"2002","unstructured":"Elving GJ, van der Mei HC, Busscher HJ, van Weissenbruch R, Albers FW. Comparison of the microbial composition of voice prosthesis biofilms from patients requiring frequent versus infrequent replacement. Ann Otol Rhinol Laryngol 2002;111:200\u2013203.","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"118_CR89","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1099\/00221287-141-1-213","volume":"141","author":"R.D. Cannon","year":"1995","unstructured":"Cannon RD, Nand AK, Jenkinson HF. Adherence of Candida albicans to human salivary components adsorbed to hydroxylapatite. Microbiology 1995;141:213\u2013219.","journal-title":"Microbiology"},{"key":"118_CR90","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/154405910208100107","volume":"81","author":"A.R. Holmes","year":"2002","unstructured":"Holmes AR, Bandara BM, Cannon RD. Saliva promotes Candida albicans adherence to human epithelial cells. J Dent Res 2002;81:28\u201332.","journal-title":"J Dent Res"},{"key":"118_CR91","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1128\/iai.58.5.1429-1436.1990","volume":"58","author":"H.F. Jenkinson","year":"1990","unstructured":"Jenkinson HF, Lala HC, Shepherd MG. Coaggregation of Streptococcus sanguis and other streptococci with Candida albicans. Infect Immun 1990;58:1429\u20131436.","journal-title":"Infect Immun"},{"issue":"pt2","key":"118_CR92","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1099\/00221287-143-2-341","volume":"143","author":"J.M. O\u2019sullivan","year":"1997","unstructured":"O\u2019sullivan JM, Cannon RD, Sullivan PA, Jenkinson HF. Identification of salivary basic proline-rich proteins as receptors for Candida albicans adhesion. Microbiology 1997;143(pt 2):341\u2013348.","journal-title":"Microbiology"},{"issue":"pt1","key":"118_CR93","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1099\/00221287-146-1-41","volume":"146","author":"J.M. O\u2019sullivan","year":"2000","unstructured":"O\u2019sullivan JM, Jenkinson HF, Cannon RD. Adhesion of Candida albicans to oral streptococci is promoted by selective adsorption of salivary proteins to the streptococcal cell surface. Microbiology 2000;146(pt 1):41\u201348.","journal-title":"Microbiology"},{"key":"118_CR94","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1128\/EC.00194-06","volume":"5","author":"C.J. Nobile","year":"2006","unstructured":"Nobile CJ, Nett JE, Andes DR, Mitchell AP. Function of Candida albicans adhesin Hwp1 in biofilm formation. Eukaryot Cell 2006;5:1604\u20131610.","journal-title":"Eukaryot Cell"},{"key":"118_CR95","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1099\/mic.0.28959-0","volume":"152","author":"X. Zhao","year":"2006","unstructured":"Zhao X, Daniels KJ, Oh SH, et al. Candida albicans Als3p is required for wild-type biofilm formation on silicone elastomer surfaces. Microbiology 2006;152:2287\u20132299.","journal-title":"Microbiology"},{"key":"118_CR96","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1371\/journal.ppat.0020063","volume":"2","author":"C.J. Nobile","year":"2006","unstructured":"Nobile CJ, Andes DR, Nett JE, et al. Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. PLoS Pathog 2006;2:e63.","journal-title":"PLoS Pathog"},{"key":"118_CR97","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1128\/AEM.67.7.2982-2992.2001","volume":"67","author":"J.M. Hornby","year":"2001","unstructured":"Hornby JM, Jensen EC, Lisec AD, et al. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl Environ Microbiol 2001;67:2982\u20132992.","journal-title":"Appl Environ Microbiol"},{"key":"118_CR98","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/jac\/dkf049","volume":"49","author":"G. Ramage","year":"2002","unstructured":"Ramage G, Bachmann S, Patterson TF, Wickes BL, Lopez-Ribot JL. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J Antimicrob Chemother 2002;49:973\u2013980.","journal-title":"J Antimicrob Chemother"},{"key":"118_CR99","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1128\/EC.00219-06","volume":"5","author":"M.A. Alem","year":"2006","unstructured":"Alem MA, Oteef MD, Flowers TH, Douglas LJ. Production of tyrosol by Candida albicans biofilms and its role in quorum sensing and biofilm development. Eukaryot Cell 2006;5:1770\u20131779.","journal-title":"Eukaryot Cell"},{"key":"118_CR100","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1128\/IAI.00438-09","volume":"77","author":"C.V. Bamford","year":"2009","unstructured":"Bamford CV, d\u2019Mello A, Nobbs AH, et al. Streptococcus gordonii modulates Candida albicans biofilm formation through intergeneric communication. Infect Immun 2009;77:3696\u20133704.","journal-title":"Infect Immun"},{"key":"118_CR101","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1111\/j.1365-2958.2004.04349.x","volume":"54","author":"D.A. Hogan","year":"2004","unstructured":"Hogan DA, Vik A, Kolter R. A Pseudomonas aeruginosa quorumsensing molecule influences Candida albicans morphology. Mol Microbiol 2004;54:1212\u20131223.","journal-title":"Mol Microbiol"},{"key":"118_CR102","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/S0966-842X(02)00002-1","volume":"11","author":"L.J. Douglas","year":"2003","unstructured":"Douglas LJ. Candida biofilms and their role in infection. Trends Microbiol 2003;11:30\u201336.","journal-title":"Trends Microbiol"},{"key":"118_CR103","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1128\/AAC.45.9.2475-2479.2001","volume":"45","author":"G. Ramage","year":"2001","unstructured":"Ramage G, Vande Walle K, Wickes BL, Lopez-Ribot JL. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 2001;45:2475\u20132479.","journal-title":"Antimicrob Agents Chemother"},{"key":"118_CR104","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1128\/AAC.42.8.1900","volume":"42","author":"G.S. Baillie","year":"1998","unstructured":"Baillie GS, Douglas LJ. Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents. Antimicrob Agents Chemother 1998;42:1900\u20131905.","journal-title":"Antimicrob Agents Chemother"},{"key":"118_CR105","doi-asserted-by":"publisher","first-page":"5385","DOI":"10.1128\/JB.183.18.5385-5394.2001","volume":"183","author":"J. Chandra","year":"2001","unstructured":"Chandra J, Kuhn DM, Mukherjee PK, et al. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 2001;183:5385\u20135394.","journal-title":"J Bacteriol"},{"key":"118_CR106","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1128\/AAC.48.9.3358-3366.2004","volume":"48","author":"C. Mateus","year":"2004","unstructured":"Mateus C, Crow SA Jr, Ahearn DG. Adherence of Candida albicans to silicone induces immediate enhanced tolerance to fluconazole. Antimicrob Agents Chemother 2004;48:3358\u20133366.","journal-title":"Antimicrob Agents Chemother"},{"key":"118_CR107","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1128\/IAI.71.8.4333-4340.2003","volume":"71","author":"P.K. Mukherjee","year":"2003","unstructured":"Mukherjee PK, Chandra J, Kuhn DM, Ghannoum MA. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect Immun 2003;71:4333\u20134340.","journal-title":"Infect Immun"},{"key":"118_CR108","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1128\/AAC.01237-06","volume":"51","author":"P. Perumal","year":"2007","unstructured":"Perumal P, Mekala S, Chaffin WL. Role for cell density in antifungal drug resistance in Candida albicans biofilms. Antimicrob Agents Chemother 2007;51:2454\u20132463.","journal-title":"Antimicrob Agents Chemother"},{"key":"118_CR109","first-page":"1","volume":"2008","author":"J. Won Song","year":"2008","unstructured":"Won Song J, Shin JH, Kee SJ, et al. Expression of CgCDR1, CgCDR2, and CgERG11 in Candida glabrata biofilms formed by bloodstream isolates. Med Mycol 2008;2008:1\u20134.","journal-title":"Med Mycol"},{"key":"118_CR110","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1128\/EC.3.2.536-545.2004","volume":"3","author":"S. Garcia-Sanchez","year":"2004","unstructured":"Garcia-Sanchez S, Aubert S, Iraqui I, et al. Candida albicans biofilms: a developmental state associated with specific and stable gene expression patterns. Eukaryot Cell 2004;3:536\u2013545.","journal-title":"Eukaryot Cell"},{"key":"118_CR111","doi-asserted-by":"publisher","first-page":"6023","DOI":"10.1128\/IAI.72.10.6023-6031.2004","volume":"72","author":"D. Andes","year":"2004","unstructured":"Andes D, Nett J, Oschel P, et al. Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect Immun 2004;72:6023\u20136031.","journal-title":"Infect Immun"},{"key":"118_CR112","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1099\/mic.0.2007\/010405-0","volume":"153","author":"R.D. Cannon","year":"2007","unstructured":"Cannon RD, Lamping E, Holmes AR, et al. Candida albicans drug resistance another way to cope with stress. Microbiology 2007;153:3211\u20133217.","journal-title":"Microbiology"},{"key":"118_CR113","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1099\/jmm.0.46569-0","volume":"55","author":"M.A. Al-Fattani","year":"2006","unstructured":"Al-Fattani MA, Douglas LJ. Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J Med Microbiol 2006;55:999\u20131008.","journal-title":"J Med Microbiol"},{"key":"118_CR114","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1128\/AAC.01056-06","volume":"51","author":"J. Nett","year":"2007","unstructured":"Nett J, Lincoln L, Marchillo K, et al. Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. Antimicrob Agents Chemother 2007;51:510\u2013520.","journal-title":"Antimicrob Agents Chemother"},{"key":"118_CR115","doi-asserted-by":"publisher","first-page":"e1000133","DOI":"10.1371\/journal.pbio.1000133","volume":"7","author":"C.J. Nobile","year":"2009","unstructured":"Nobile CJ, Nett JE, Hernday AD, et al. Biofilm matrix regulation by Candida albicans Zap1. PLoS Biol 2009;7:e1000133.","journal-title":"PLoS Biol"},{"key":"118_CR116","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1128\/AAC.00684-06","volume":"50","author":"M.D. LaFleur","year":"2006","unstructured":"LaFleur MD, Kumamoto CA, Lewis K. Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob Agents Chemother 2006;50:3839\u20133846.","journal-title":"Antimicrob Agents Chemother"},{"key":"118_CR117","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1128\/AAC.46.11.3591-3596.2002","volume":"46","author":"S.P. Bachmann","year":"2002","unstructured":"Bachmann SP, VandeWalle K, Ramage G, et al. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother 2002;46:3591\u20133596.","journal-title":"Antimicrob Agents Chemother"},{"key":"118_CR118","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1093\/jac\/dkp242","volume":"64","author":"A.L. Lazzell","year":"2009","unstructured":"Lazzell AL, Chaturvedi AK, Pierce CG, et al. Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis. J Antimicrob Chemother 2009;64:567\u2013570.","journal-title":"J Antimicrob Chemother"},{"key":"118_CR119","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1086\/506452","volume":"194","author":"J.A. Shuford","year":"2006","unstructured":"Shuford JA, Rouse MS, Piper KE, Steckelberg JM, Patel R. Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model. J Infect Dis 2006;194:710\u2013713.","journal-title":"J Infect Dis"},{"key":"118_CR120","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1128\/AEM.02439-06","volume":"73","author":"N. Jain","year":"2007","unstructured":"Jain N, Kohli R, Cook E, et al. Biofilm formation by and antifungal susceptibility of Candida isolates from urine. Appl Environ Microbiol 2007;73:1697\u20131703.","journal-title":"Appl Environ Microbiol"},{"key":"118_CR121","doi-asserted-by":"publisher","first-page":"e5392","DOI":"10.1371\/journal.pone.0005392","volume":"4","author":"A. Torosantucci","year":"2009","unstructured":"Torosantucci A, Chiani P, Bromuro C, et al. Protection by antibeta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence. PLoS One 2009;4:e5392.","journal-title":"PLoS One"},{"key":"118_CR122","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nrmicro1680","volume":"5","author":"W.J. Steinbach","year":"2007","unstructured":"Steinbach WJ, Reedy JL, Cramer RA Jr, Perfect JR, Heitman J. Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections. Nat Rev Microbiol 2007;5:418\u2013430.","journal-title":"Nat Rev Microbiol"},{"key":"118_CR123","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1128\/AAC.01397-07","volume":"52","author":"P. Uppuluri","year":"2008","unstructured":"Uppuluri P, Nett J, Heitman J, Andes D. Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms. Antimicrob Agents Chemother 2008;52:1127\u20131132.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Odontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10266-009-0118-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10266-009-0118-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10266-009-0118-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10266-009-0118-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T22:28:14Z","timestamp":1659047294000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10266-009-0118-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":123,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["118"],"URL":"https:\/\/doi.org\/10.1007\/s10266-009-0118-3","relation":{},"ISSN":["1618-1247","1618-1255"],"issn-type":[{"value":"1618-1247","type":"print"},{"value":"1618-1255","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"9 November 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}